The Department of Neurology outpatient practices are OPEN for in person visits and we will also continue to offer Video Visits.

For information about COVID-19, please read our COVID-19 patient guide. Due to the COVID-19 pandemic we have reduced face-to-face patient encounters. However, our team of Neurologists can handle a lot of your follow-up and new neurologic care via a Video Visit. Video Visits are also available for follow-up appointments and new patient visits to New York State, Florida, New Jersey and Connecticut residents. Please call (212) 746-2596 to schedule a Video Visit.
Neurology

You are here

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)

Full Title: 
Randomized, multicenter, double-blind, placebo-controlled, parallel-group phase III study to investigate the efficacy, safety, and tolerability of 2 different doses of IgPro20 (subcutaneous immunoglobulin) for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) - the PATH study Protocol IgPro20_3003
Specialty: 
Status: 
Principle Investigator: 
Norman Latov, MD, PhD
Contact Phone : 
(646) 962-2149
Additional Cornell Investigator: 
Russell L. Chin, MD Jennifer A. Langsdorf, MD

To read more about this study visit the ClinicalTrials.gov page here.

Weill Cornell Medicine Neurology 520 East 70th Street (at York Avenue) Starr Pavilion 607 New York, NY 10021 Phone: (212) 746-2596